Search Results 221-230 of 22999 for Phase

1. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

   About this study. Patients with high tumor burden, low grade follicular lymphoma that has never been treated, will receive venetoclax in combination with ...

2. Allergy shots - Mayo Clinic

   To be effective, allergy shots are given on a schedule that involves two phases: The buildup phase generally takes 3 to 6 months. Typically, shots are given ...

3. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

   Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer · Share · Facebook · Twitter.

4. A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients - Mayo Clinic

   A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of ...

5. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

   A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) · More about research at Mayo Clinic.

6. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer - Mayo Clinic

   A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate ...

7. Phase 1a/​1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers - Mayo Clinic

   Phase 1a/​1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers · Overview.

8. centers-of-excellence

   Overview Tab Title Description Study type Interventional Study phase 4 Study IDs Study type Interventional Describes the nature of a ...

9. Phase 2a Study Of VX-407 In Participants With ADPKD Who Have A Subset Of PKD1 Gene Variants (AGLOW) - Mayo Clinic

   Phase 2a Study Of VX-407 In Participants With ADPKD Who Have A Subset Of PKD1 Gene Variants (AGLOW) · Overview · Participation eligibility · Participating Mayo ...

10. Tolerability, safety and deep response found in cevostamab phase 1 trial - Mayo Clinic

    A midterm analysis of a multisite phase 1 study of cevostamab for relapsed or refractory multiple myeloma (RRMM) finds the drug safe and tolerable with deep ...